Status:
COMPLETED
Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen
Lead Sponsor:
Seoul National University Hospital
Conditions:
Ibuprofen
Remifentanil
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Postoperative hyperalgesia has been reported after intraoperative administration of small or high-dose remifentanil. Cyclooxygenase inhibitor exhibit preventive effects on the development of opioid-in...
Eligibility Criteria
Inclusion
- Adult patients scheduled for elective pancreaticoduodenectomy
Exclusion
- Patients with chronic pain
- Patients with psychiatric disease
- Patients with nonsteroidal antiinflammatory drugs allergy
- Patients with renail dysfunction
- History of drug addiction
- Pregnant patient
- Inability to use a PCA device
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02243254
Start Date
July 1 2014
Last Update
November 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea